Hetrombopag Olamine Tablet ( DrugBank: Hetrombopag )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
60	再生不良性貧血	3

60. 再生不良性貧血

---

臨床試験数 : 235 /  薬物数 : 381 - (DrugBank : 83) / 標的遺伝子数 : 44 - 標的パスウェイ数 : 160

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05088655 (ClinicalTrials.gov)	June 25, 2021	12/10/2021	A Bioequivalence Study of Hetrombopag in Healthy Subjects	Bioequivalence Study of Different Formulations of Hetrombopag Olamine Tablets in Healthy Subjects	Sever Aplastic Anaemia	Drug: Hetrombopag Olamine Tablet	Jiangsu HengRui Medicine Co., Ltd.	NULL	Recruiting	18 Years	45 Years	All	57	Phase 1	China
2	NCT05088642 (ClinicalTrials.gov)	September 28, 2020	12/10/2021	A Trial of Hetrombopag in Healthy and Hepatic Impairment Subjects	A Phase I Clinical Study Evaluating the Pharmacokinetics and Safety of Hetrombopag Olamine Tablets in Subjects With Mild Hepatic Impairment (Child-Pugh Class A), Moderate Hepatic Impairment (Child-Pugh Class B), and Normal Hepatic Function	Sever Aplastic Anaemia	Drug: Hetrombopag Olamine Tablet	Jiangsu HengRui Medicine Co., Ltd.	NULL	Completed	18 Years	65 Years	All	24	Phase 1	China
3	NCT05088174 (ClinicalTrials.gov)	September 3, 2020	12/10/2021	A Trial of Hetrombopag in Healthy Subjects	A Single-Center, Single-Arm, Open-Label, Self-Controlled, Drug-Drug Interaction Study of Hetrombopag Olamine and Ciclosporin in Healthy Subjects	Sever Aplastic Anaemia	Drug: Hetrombopag Olamine Tablet;Ciclosporin Soft Capsule	Jiangsu HengRui Medicine Co., Ltd.	NULL	Completed	18 Years	65 Years	All	26	Phase 1	China